coach on RB: I can't tell you what to do with your shares. I can, however, give you some fat to chew on...market forces are going to be at work here for the next several months, and the sentiment is not good; you can't exactly feel the love in the room. Many shares are going to wash on shore over at CYCR and with the large float they won't be able to absorb them. Things changed here because the company changed things. There is no catalyst for this to move up, yet there are plenty of factors pushing it down. Concerns from the medical community about EndoScan's saline liquid based method being too invasive and causing cramping and bleeding; the fiscal skullduggery of an rs which drives our eps to (-.40) overnight; figurehead CEO's and a puppet master CFO; disdain and disregard for holders of common shares; fur trap pr's. Whether you sell or not is up to a kitchen table discussion between you and your wife. I would, however, dissuade you from buying here. There's plenty of quality out there right now with a broad market of attractive P/E's. Silver intrigues me, and BLUD is a good place to rest and detoxify in a safe environment---they're holding a conference call tomorrow open to all investors to discuss earnings and other topics. Imagine, a CEO dining with the unwashed, speaking to him as if he were an equal in words other than "bring my car around front". Maybe that's why I've watched them go from $6 to $36 in two years. I don't care if you buy Immucor or not, but emotions are running high here and it might be best to step back and just watch. I won't touch this until I see earnings. Not revenues. Earnings.
Market Data 
Markets 
AI
